The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
An algorithm based testing for Fatty Liver Disease
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)